Ekso Bionics Holdings, Inc. (EKSO) Financials

EKSO Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 28.9 million 16.3 million
2023-09-30 31.2 million 15.9 million
2023-06-30 34.0 million 16.2 million
2023-03-31 37.1 million 15.8 million

EKSO Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -1.6 million 553000
2023-09-30 -3.4 million 526000
2023-06-30 -3.0 million 640000
2023-03-31 -4.3 million 517000

EKSO Net Income

No data available :(

EKSO Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 8.6 million - 1.1 million
2023-09-30 9.9 million - 1.2 million
2023-06-30 13.3 million - 1.3 million
2023-03-31 16.3 million - 1.3 million

EKSO Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 14.4 million
2023-09-30 14.1 million
2023-06-30 13.6 million
2023-03-31 13.3 million

EKSO Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 43000 1.3 million 2.5 million 2.0 million
2023-09-30 17000 1.2 million 2.2 million 2.1 million
2023-06-30 55000 1.4 million 2.8 million 2.3 million
2023-03-31 42000 1.2 million 3.2 million 2.1 million

EKSO Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 4.8 million 2.5 million
2023-09-30 4.6 million 2.2 million
2023-06-30 4.7 million 2.4 million
2023-03-31 4.1 million 2.1 million

EKSO

Price: $1.36

52 week price:
0.62
3.13

Earnings Per Share: -1.10 USD

P/E Ratio: -1.79

Exchange: NCM

Sector: Healthcare

Industry: Medical Instruments & Supplies

Volume: 30100

Ebitda: -6.6 million

Market Capitalization: 23.8 million

Links: